Webwith our partners in government, academia, industry and the investment community, if we focus on these three things: building companies, building ecosystems, and building talent, we will realize our vision of Canadian life sciences leading the world. Gordon C. McCauley President & CEO, adMare BioInnovations What’s new in our community See all news WebAccess the latest Thryv Therapeutics' news and progress. We have been pioneering a precision medicine approach to treat Long QT Syndrome via SGK1 inhibition since 2024, and our portfolio has evolved to include the treatment of resistant and rare cancers.

OUR TECHNOLOGY Jenthera Therapeutic

WebMar 15, 2024 · Kintara Therapeutics leadership team is committed to contributing to the battle against cancer by researching and developing novel cancer therapies that treat patients with significant unmet clinical need. Management Team Board of Directors Kintara Therapeutics, Inc. Nasdaq: KTRA Day Range View Investor Relations View Investor … WebWELCOME TO KAIROS PHARMA Cutting-edge therapeutics for cancer patients. About us Kairos Pharma is a clinical-stage biopharmaceutical company focused on developing a diversified pipeline of cutting-edge oncology therapeutics that reverse the inhibitory effects of cancer on the immune system. tahsean hodge

TIAP - Toronto Innovation Acceleration Partners’ Post

WebToronto, Inteligex Inc. Type Privately Held Founded 2024 Specialties Stem Cells, Spinal Cord Injury, Neural Stem Cells, and Central Nervous System Locations Primary 100 College … WebJenthera Therapeutics Inc. Biotechnology Research Toronto, Ontario 359 followers We are a CRISPR gene editing platform company, correcting and disrupting genes to develop … WebMr Philip Roche. Director at Jenthera Therapeutics Inc. Experience. Galengrowth Present - Present. Education. Galengrowth Univesity. tahs class of 1977